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Abstract 
This paper investigates the use of PCL and PCL/PLA scaffolds produced using a novel additive biomanufacturing system called 
BioCell Printing. PCL/PLA blends were prepared using melt blend and solvent casting techniques.  Scaffolds with 0/90º 
architecture and 350 μm of pore size were morphologically evaluated using scanning electron microscopy and atomic force 
microscopy. Biological tests, using osteosarcoma cell line G-63, were performed using the Alamar Blue Assay and Alkaline 
Phosphatase Activity.  
Results show that the BioCell Printing system produces scaffolds with regular and reproducible architecture, presenting no toxicity 
and enhancing cell attachment and proliferation. It was also possible to observe that the addition of PLA to PCL scaffolds strongly 
improves the biomechanical performance of the constructs.  
  
© 2012 The Authors. Published by Elsevier B.V. Selection and/or peer-review under responsibility of Professor Mamoru Mitsuishi 
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1. Introduction 
Scaffolds are used in tissue engineering as a physical 
and biological support for seeding cells, and 
transplanting them into an organism [1-11]. Scaffolds are 
critical as they serve different purposes: allow cell 
attachment, proliferation and differentiation, deliver and 
retain cells and growth factors, enable diffusion of cell 
nutrients and oxygen, and enable the establishment of an 
appropriate mechanical and biological environment for 
tissue regeneration in an organised way [1-11]. 
Poly (İ-caprolactone) (PCL) is extensively used to 
produce scaffolds for tissue engineering applications due 
to its biocompatibility, biodegradability, structural 
stability and mechanical properties. However, PCL 
presents low bioactivity and surface energy (high 
hydrophobicity), leading to reduced cell affinity and 
small tissue regeneration rates. This paper describes a 
strategy to reduce these limitations by combining PCL 
with Poly-lactic acid (PLA) in order to produce less 
hydrophobic constructs with adjustable degradability 
and appropriated mechanical properties. PCL/PLA 
mixtures, prepared by solvent casting and melt blending, 
were used to produce the scaffolds by using an additive 
biomanufacturing system called BioCell Printing [12]. 
Scaffolds were characterised from both morphological a 
biological views.  
2. Materials and Methods  
2.1. Materials 
PCL is a semi-crystalline linear aliphatic polyester 
susceptible to undergo autocatalyzed bulk hydrolysis and 
slow degradation [13]. PCL has a low melting point 
(§60ºC), which enables easy processing and a low glass 
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transition temperature (§-60ºC), which allows high 
elasticity at room and body temperature [7]. PLA is a 
biocompatible and resorbable aliphatic polyester 
characterized by its high melting temperature (§160ºC) 
and glass transition temperature (§60ºC) [14]. 
The PCL used in this research work was Capa 6500 
(Perstorp, UK), and the PLA was PLA 2002D (Cargill 
Down, USA). 
 
2.1.1 Physical blending  
 
The blending process of PCL and PLA (50/50 wt%) 
was performed using two different methods: melt 
blending and solvent casting. In both methods, the 
blends were prepared using 55g of each material. 
The melt blending method was carried out using a 
Plastograph® EC mixer (Brabender® GmBH & Co. KG, 
Germany) at 160 ºC and 40 rpm, during 5 min. Once the 
films produced, they were cut and placed in desiccators 
to avoid material degradation.   
In the second method, PCL and PLA were 
solubilized in chloroform using two different glass 
containers kept under stirring (300rpm) during 8 hours. 
Once completely dissolved, both solutions were mixed, 
in order to produce the PCL/PLA blends. The mixture 
was placed into a petri disk to produced thin films. The 
solvent was slowly evaporated in a laboratory fume 
hood. The residual solvent was removed by vacuum 
drying during 24 hours. Finally, similarly to the first 
method, the films were cut in small pieces, and placed 
into desiccators to avoid material degradation. 
2.2. Methods 
2.2.1 Scaffold Fabrication  
 
PCL and PCL/PLA scaffolds were produced using 
the BioCell Printing system (Fig. 1), being developed by 
the Centre for Rapid and Sustainable Product 
Development of the Polytechnic Institute of Leiria 
(Portugal). This is a novel additive biomanufacturing 
system that enables the integration and synchronization 
of the different stages of production and culture of 3D 
matrices with reduced manual intervention [12]. 
Depending on the chosen strategies (acellular or cellular 
scaffolds), a precision robotic arm transfers the 3D scaffolds 
between the construction area (zone 1) to zone 2, where 
they are sterilized. After sterilization, scaffolds are 
homogenously seeded with cells using a robotic dispenser 
(zone 3). Finally, 3D constructs with embedded or seeded 
cells are cultured in vitro under dynamic conditions in the 
bioreactor (zone 4). The integration of the different stages 
into a single device significantly reduces the risk of 
contamination and increases productivity and the possibility 
of direct clinical application. 
All scaffolds were produced using a lay down pattern 
of 0/90, pore size of 350 μm and slice thickness of 280 
μm, as shown in Fig. 2. The adopted fabrication strategy 
is illustrated in Fig.3. PCL was processed at 80ºC while 
PCL/PLA was processed at 180ºC. In both cases de 
deposition velocity was 17 mm/s. 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Biocell Printing system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Design parameters. 
 
 
Fig. 3. Scaffold’s fabrication strategy. 
Slice Thickness (ST) = 280 μm 
Filament Distance (FD) = 650μm
Filament Width (FW) = 350μm
Pore Size (PS) = 350μm 
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2.2.2 Morphological characterization  
 
Two techniques were considered for the 
morphological characterization of the produced 
scaffolds: scanning electron microscopy (SEM) and 
atomic force microscopy (AFM).   
SEM tests were performed using the FEI QUANTA 
600F system (FEI Company, USA). All scaffolds were 
cut in blocks of 4.0 mm of length (l), 4.0 mm of width 
(w) and 8.0 mm of height (h0), and the images were 
obtain from frontal face and side cutting. All dimensions 
were measured using the software Image J. The average 
and standard deviation from 10 measurements were 
reported for each sample group. 
AFM uses a flexible cantilever as a type of spring to 
measure the force between the tip and the sample and 
was used to determine surface roughness. All 
measurements were obtained using the NanoWizard 
system (maximum scan range: 100x100 μm; z-range: 15 
μm; spring constant: 2N/m) with TopViewOptics 
software (JPK instruments, Germany).    
 
2.2.2 Biological characterisation  
 
Biological studies were performed on PCL and 
PCL/PLA scaffolds. Two methods were considered: the 
Alamar Blue Assay and Alkaline Phosphatase Activity.  
Alamar blue was used to measure cell viability and 
proliferation. This is a sensitive oxidation-reduction 
indicator that fluoresces and changes colour upon 
reduction mitochondrial enzymes [15-17].  
Samples were sterilized with 70% ethanol/water 
solution for 24 hours, washed with PBS 0.01M, pH 7.4 
and exposed to U.V. light during 40 minutes.  3D 
scaffolds (5 mm × 5 mm × 3.36 mm) were seeded with 
MG-63 cells, using a density of 17ൈ103 cells/sample. 
The number of viable cells is correlated with the 
magnitude of dye reduction and is expressed as a 
percentage of Alamar Blue reduction. 
Alkaline phosphatase (ALP) is one of the most 
important osteoblast differentiation marker protein [18]. 
Alkaline Phosphatase Activity measurements were used 
to evaluate the osteogenic expression of MG-63 cells, 
since ALP is an early marker for the osteogenic cell 
differentiation. A density of 70×103 cells/sample was 
used and a specific biochemical assay was applied to 
measure ALP activity (SensoLyte® pNPP Alkaline 
Phosphatase Assay Kit).  
3. Results and Discussion  
3.1 Morphological characterisation 
  
Fig. 4 shows the SEM micrographs of PCL and 
PCL/PLA scaffolds. From this figure it is possible to 
observe that all scaffolds present a well defined internal 
geometry and uniform pore distribution. The values 
obtained for the pore size (PS), filament width (FW), 
slice thickness (ST) and filament distance (FD) are 
summarized in Table 1. 
Results show that PCL scaffolds present values close 
to the theoretical ones (input values). In the case of 
PCL/PLA scaffolds, it is possible to observe that the 
method used to prepare the blends determines the 
geometrical characteristics of the final scaffolds. The 
differences observed for PCL scaffolds and PCL/PLA 
scaffolds are due to viscosity differences, caused by the 
higher temperature required to extrude PCL/PLA 
scaffolds (180ºC).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. SEM micrographs of the scaffolds. a) PCL scaffold; b) 
PCL/PLA scaffold - blends prepared by melt blending; c) PCL/PLA 
scaffold- blends prepared by solvent casting. 
Table 1. Design parameters (average of 10 measurements with ± 
standard deviation).  
 
 
Theoretical 
values [μm] 
PCL 
scaffold  
[μm] 
PCL/PLA 
scaffold - 
blends 
prepared 
by melt 
blending 
[μm] 
PCL/PLA 
scaffold -  
blends 
prepared by 
solvent 
casting  
[μm] 
PS  350 354,4 ± 3,9 311,6 ± 17 294 ± 12 
FW 300 310 ± 9,5 414,8 ± 12 434 ± 27 
ST  280  263 ± 13,7 288 ± 14,8 367 ± 27,7 
FD  650 647,2 ± 27 678േ37 651 ± 10 
Cross View
b
c
a
ST 
FD FW 
b
c
Front View
PS 
a 
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AFM measurements (Fig. 5) show that scaffolds 
produced with blends prepared by melt blending present 
smooth surfaces. In this case it is also possible to 
observe the presence of nanoscale fibres on the surface 
of the scaffold filaments. The nanoscale topography of 
the scaffolds produced with blends prepared by solvent 
casting is favourable for cell attachment, proliferation 
and differentiation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Surface characteristics PCL/PLA scaffolds. a) Optical pictures 
of both the silicon cantilever and the PCL/PLA scaffold (blend 
prepared by melt blending); b) AFM micrograph of the PCL/PLA 
scaffold (blend prepared by melt blending); c) Optical pictures of both 
the silicon cantilever and the PCL/PLA scaffold (blend prepared by 
solvent casting); d) AFM micrograph of the PCL/PLA scaffold (blend 
prepared by solvent casting).  
3.2 Biological Characterisation 
 
Alamar Blue Assay  
A preliminary biological evaluation of PCL and 
PCL/PLA scaffolds to sustain cell adhesion and 
proliferation was carried out using osteosarcome MG-
63. Quantitative evaluation of cells was performed after 
7 and 14 days of static cell culture by means of Alamar 
Blue. The percentage of Alamar Blue reduction is 
reported in Table 2. 
 
Table 2. Results obtained from Alamar BlueTM assay at 7 and 14 days. 
 
 % Reduction Alamar BlueTM 
Scaffold 7 days 14 days 
PCL scaffold 8.08 ± 1.06 25.80 ± 0.40 
PCL/PLA scaffold  - blends 
prepared by melt blending 10.18 ± 1.10 19.20 ± 9.14 
PCL/ PLA scaffold  - 
blends prepared by solvent 
casting 
14.34 ± 1.08 46.80 ± 3.51 
 
These results allow us to conclude that, 
independently of the material, all scaffolds are able to 
sustain cell adhesion and proliferation. Additionally, it is 
possible to observe an increment in terms of % reduction 
of Alamar Blue from day 7 to day 14, which corresponds 
to an increment of cell viability.  
The addition of PLA into the PCL matrix clearly 
enhances cell adhesion and proliferation, possible due to 
the higher hydrophilic characteristics of PLA.  
From a biological point of view, it is also interesting 
to note that the PCL/PLA blend preparation method has 
a strong influence on the adhesion and proliferation of 
MG-63 cells.  Higher cell proliferation was observed on 
PCL/PLA scaffolds prepared by solvent casting. The low 
biological performance of PCL/PLA scaffold blend 
prepared by melt blending is probably due to the smooth 
surface of the scaffolds that reduces cell attachment and 
the heterogeneous distribution of PLA within the PCL 
matrix.   
 
 
Alkaline Phosphatase   
The osteogenic differentiation of the MG-63 cells 
was assessed by ALP activity (%) and is indicated in 
Table 3. 
The significant increase of the ALP activity, from 
day 7 to 14, indicates cell differentiation during this 
period. From day 14 to 21, the osteogenic differentiation 
process decreases, probably due to cell colonization. 
These results highlight the ability of the produced 
scaffolds to allow the osteogenic differentiation of MG-
63 cells, independently of the material used. 
 
Table 3. Alkaline phosphatase (ALP) activity (%) at 7, 14 and 21 days. 
ALP Activity (%) [ng ALP/ng DNA] 
Scaffold 7 days 14 days 21 days 
PCL scaffold 1.61 ± 0.53 9.38 ± 1.86 3.01 ± 0.99 
PCL/PLA 
scaffold blend 
prepared by 
melt blending 
1.91 ± 0.66 9.49 ± 1.89 6.55 ± 1.97 
PCL/ PLA 
scaffold blend 
prepared by 
solvent casting 
1.87 ± 0.56 9.54 ± 1.91 3.45 ± 1.04 
 
4. Conclusion  
This research work investigates the use of PCL and 
PCL/PLA scaffolds produced with mixtures prepared by 
solvent casting and melt blending. Results show that 
PCL/PLA scaffolds present a better biological 
behaviour.  Additionally, it was possible to observe that 
the blending method strongly determines the scaffold 
surface roughness and cell adhesion and proliferation.  
PCL/PLA scaffolds produced from blends prepared by 
solvent casting, present a reduced pore size, which also 
enhances cell proliferation.   
a b 
 
c d 
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